| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T731 |
0-159 |
Sentence |
denotes |
Several therapeutic agents, such as lopinavir/ritonavir, chloroquine, and hydroxychloroquine, have been proposed for the clinical management of COVID-19 (299). |
| T732 |
160-492 |
Sentence |
denotes |
A molecular docking study, conducted in the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 using different commercially available antipolymerase drugs, identified that drugs such as ribavirin, remdesivir, galidesivir, tenofovir, and sofosbuvir bind RdRp tightly, indicating their vast potential to be used against COVID-19 (305). |
| T733 |
493-721 |
Sentence |
denotes |
A broad-spectrum antiviral drug that was developed in the United States, tilorone dihydrochloride (tilorone), was previously found to possess potent antiviral activity against MERS, Marburg, Ebola, and Chikungunya viruses (306). |
| T734 |
722-806 |
Sentence |
denotes |
Even though it had broad-spectrum activity, it was neglected for an extended period. |
| T735 |
807-886 |
Sentence |
denotes |
Tilorone is another antiviral drug that might have activity against SARS-CoV-2. |
